Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Translating Oxford

discoveries into 

life-saving applications

Donate Today

News

SELINA cohort logo

National clinical study launched to test new technologies for detecting liver cancer

The SELINA study will recruit patients with early liver cancers as part of the DeLIVER programme aiming to detect liver cancer earlier.

Woman receiving a vaccination

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

Previous news posts

Become part of the Oxford Cancer community & contribute to a world where cancers are diagnosed earlier and treated more effectively

Join our membership

Our research will

mean better care

for cancer patients

Discover Oxford's research

Staff Services